This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Early Geriatric Evaluation and Treatment in Patien...
Clinical trial

Early Geriatric Evaluation and Treatment in Patients With Advanced Lung Cancer. A Pilot

Read time: 1 mins
Last updated:19th Feb 2014

A Pilot. Randomised Controlled study. Early geriatric assessment and tailored treatment applied to patients with widespread Non Small Cel lung Cancer (NSCLC). On the day of planning the oncologic treatment Comprehensive Geriatric Assessment (CGA) will be offered to patients aged 60 and up. Based on the CGA a tailored multidisciplinary intervention is planned with the patients. The study aim is to test different screening methods to find the best suited method to select the frail geriatric patients in order to be able to select the frail patients in a planned later study, estimate the effect of CGA on these patients in order to be able to calculate the needed number of patients and to estimate the time consumption in this latter study . The hypothesis is that the screening method G8 is superior to Performance Status(PS) and clinical oncologist´ evaluation and that CGA improves survival amongst Patients aged 60 or more with NSCLC and prevents hospitalisation and complications to the oncologic treatment.

Category Value
Study start date 2014-02-19

View full details